Ramón Mangues (Ramon Mangues)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Pharmaceutics

Cancers

Diagnostics (Basel, Switzerland)

Biomedicines

Hospital de la Santa Creu i Sant Pau Institut de Recerca

Universidad de Navarra (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de la Santa Creu i Sant Pau Institut de Recerca Dec 31 2005

Spain

Research Professor (Investigador Titular)

Hospital de la Santa Creu i Sant Pau Institut de Recerca Jan 01 1998 - Dec 30 2005

Spain

Researcher :: Research Institute

New York University Oct 01 1993 - Dec 31 1997

United States

Assistant Research Scientist :: New York University Medical Center

New York University Apr 01 1988 - Oct 01 1993

United States

Postdoctoral Researcher :: New York University Medfical Center

Clinica Universitaria de Navarra Jan 01 1982 - Apr 01 1988

Spain

Hospital Pharmacist :: Pharmacy

Education History

Universidad de Navarra Apr 01 1983 - Apr 01 1998

Spain

PHD :: Pharmacy Department

Publications

Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Naroa Serna, Aïda Falgàs, Annabel García-León, Ugutz Unzueta, Yáiza Núñez, Alejandro Sánchez-Chardi, Carlos Martínez-Torró, Ramón Mangues, Esther Vazquez, Isolda Casanova, Antonio Villaverde
Time-Prolonged Release of Tumor-Targeted Protein-MMAE Nanoconjugates from Implantable Hybrid Materials. Pharmaceutics 14 (1) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Esperanza Medina-Gutiérrez, María Virtudes Céspedes, Alberto Gallardo, Elisa Rioja-Blanco, Miquel Àngel Pavón, Laura Asensio-Puig, Lourdes Farré, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vázquez, Isolda Casanova, Ramón Mangues
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease. Biomedicines 10 (7) (2022)
Elisa Rioja-Blanco, Alberto Gallardo, Irene Arroyo-Solera, Patricia Álamo, Isolda Casanova, Ugutz Unzueta, Naroa Serna, Laura Sánchez-García, Miquel Quer, Antonio Villaverde, Esther Vazquez, Xavier Leon Vintro, Lorena Alba-Castellón, Ramón Mangues
A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model. Pharmaceutics 14 (4) (2022)
Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo, Patricia Álamo, Lorena Alba-Castellón, Ugutz Unzueta, Antonio Villaverde, Esther Vazquez, Isolda Casanova, Ramón Mangues
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers 15 (1) (2022)
Olivia Cano-Garrido, Patricia Álamo, Laura Sánchez-García, Aïda Falgàs, Alejandro Sánchez-Chardi, Naroa Serna, Eloi Parladé, Ugutz Unzueta, Mònica Roldán, Eric Voltà-Durán, Isolda Casanova, Antonio Villaverde, Ramón Mangues, Esther Vazquez
Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4+ Cancers. Cancers 13 (12) (2021)
Aïda Falgàs, Victor Pallarès, Ugutz Unzueta, Yáiza Núñez, Jorge Sierra, Alberto Gallardo, Lorena Alba-Castellón, Maria Antonia Mangues, Patricia Álamo, Antonio Villaverde, Esther Vázquez, Ramón Mangues, Isolda Casanova
Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4+ Diffuse Large B-Cell Lymphoma Cells. International journal of nanomedicine 16 (2021)
Naroa Serna, José Vicente Carratalá, Oscar Conchillo-Solé, Carlos Martínez-Torró, Ugutz Unzueta, Ramón Mangues, Neus Ferrer-Miralles, Xavier Daura, Esther Vazquez, Antonio Villaverde
Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics 13 (11) (2021)
Anna Aviñó, Ugutz Unzueta, María Virtudes Céspedes, Isolda Casanova, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Ramón Eritja
Efficient bioactive oligonucleotide-protein conjugation for cell-targeted cancer therapy. ChemistryOpen 8 (3) (2019)
María Virtudes Céspedes, Ugutz Unzueta, Anna Aviñó, Alberto Gallardo, Patricia Álamo, Rita Sala, Alejandro Sánchez-Chardi, Isolda Casanova, María Antònia Mangues, Antonio Lopez-Pousa, Ramón Eritja, Antonio Villaverde, Esther Vázquez, Ramón Mangues
Selective depletion of metastatic stem cells as therapy for human colorectal cancer. EMBO molecular medicine 10 (10) (2019)
Irene Arroyo-Solera, Miguel Ángel Pavón, Xavier Leon Vintro, Montserrat López, Alberto Gallardo, María Virtudes Céspedes, Isolda Casanova, Víctor Pallarès, Antonio López-Pousa, María Antonia Mangues, Agustí Barnadas, Miquel Quer, Ramón Mangues
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma. Head & neck 41 (2) (2018)
María José Moreno, Alberto Gallardo, Silvana Novelli, Ana Mozos, Marc Aragó, Miguel Ángel Pavón, María Virtudes Céspedes, Víctor Pallarès, Aïda Falgàs, Miguel Alcoceba, Oscar Blanco, Marcos Gonzalez-Díaz, Jorge Sierra, Ramón Mangues, Isolda Casanova
CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis. PloS one 13 (6) (2018)
Victor Pallarès, Montserrat Hoyos, María Carmen Chillón, Eva Barragán, M Isabel Prieto Conde, Marta Llop, Aïda Falgàs, María Virtudes Céspedes, Pau Montesinos, Josep F Nomdedeu, Salut Brunet, Miguel Ángel Sanz, Marcos González-Díaz, Jorge Sierra, Ramón Mangues, Isolda Casanova
Focal Adhesion Genes Refine the Intermediate-Risk Cytogenetic Classification of Acute Myeloid Leukemia. Cancers 10 (11) (2018)
Simon Body, Anna Esteve-Arenys, Hadjer Miloudi, Clara Recasens-Zorzo, Guergana Tchakarska, Alexandra Moros, Sophie Bustany, Anna Vidal-Crespo, Vanina Rodriguez, Régis Lavigne, Emmanuelle Com, Isolda Casanova, Ramón Mangues, Oliver Weigert, Alejandra Sanjuan-Pla, Pablo Menéndez, Bénédicte Marcq, Jean-Michel Picquenot, Patricia Pérez-Galán, Fabrice Jardin, Gael Roué, Brigitte Sola
Cytoplasmic cyclin D1 controls the migration and invasiveness of mantle lymphoma cells. Scientific reports 7 (1) (2017)
Ramón Mangues, Esther Vázquez, Antonio Villaverde
Targeting in Cancer Therapies. Medical sciences (Basel, Switzerland) 4 (1) (2016)

Ramón Mangues.css-eqlu8i{font-size:small;padding-left:4px;} (Ramon Mangues)

Publication Activity (10 Years)

Top Topics

Top Venues

Ramón Mangues (Ramon Mangues)